ASMI sponsors new complementary medicines research leadership program
30 September 2014 - The Australian Self Medication Industry (ASMI) is proud to support a unique program for up and coming complementary medicine researchers at the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) at the University of Technology, Sydney. This international leadership program is aimed at growing critical scientific research in complementary and integrative medicine.
The program, which commences tomorrow, brings together twelve
'rising stars' in complementary medicine research from Sweden, the
UK, Hong Kong, Canada, Germany, New Zealand, USA and Australia. It
is a world-first program to help develop the next generation of
leaders in the field and encourage international
All successful fellows have been appointed due to their impressive track records and strong methodological grounding across a number of disciplines including health services research, public health, epidemiology and clinical science.
Known as ARCCIM Leadership Fellows, participants will initially spend four days at UTS building capacity for their own research as well as planning international collaborative research strategies.
Dr Deon Schoombie, ASMI Executive Director said: "There is a rigorous body of complementary medicines research emerging around the world. ASMI is committed to both funding independent research and supporting researchers to build the evidence base for complementary medicines.
"The Leadership Program should stimulate researchers around the world to add to the body of knowledge about complementary medicines.
"ARCCIM's Leadership Program is inspiring. I congratulate the
ARCCIM Team for launching it," added Dr Schoombie.
About ASMI: The Australian Self-Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy (www.asmi.com.au).
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: email@example.com